Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
about
Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugsParkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cellsX-ray structure of dopamine transporter elucidates antidepressant mechanismVanoxerine: cellular mechanism of a new antiarrhythmicThe variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter densityInteractive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDSDifferential effects of dopamine-directed treatments on cognitionImmunomodulatory Effects Mediated by DopamineCloning and sequence analysis of cDNAs encoding the heavy and light chain variable regions of an Ab2beta anti-idiotypic monoclonal antibody possessing an internal image of cocaineInvolvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptakeNeuroanatomical study of the A11 diencephalospinal pathway in the non-human primateClassic Studies on the Interaction of Cocaine and the Dopamine TransporterThe moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine.Subcellular localization of the antidepressant-sensitive norepinephrine transporter.Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysisOocytes are a source of catecholamines in the primate ovary: evidence for a cell-cell regulatory loop.Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emissionEffect of serotonin on platelet function in cocaine exposed bloodDopaminergic Control of Attentional Flexibility: Inhibition of Return is Associated with the Dopamine Transporter Gene (DAT1)Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle.Functional analysis of upstream common polymorphisms of the dopamine transporter gene.Pharmacogenetics of antidepressant response.Exogenous visual orienting is associated with specific neurotransmitter genetic markers: a population-based genetic association studyThe second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride.Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties.Regulation of monoamine transporters: Role of transporter phosphorylation.Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulationRegulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Dopamine genes and attention-deficit hyperactivity disorder: a review.Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster.Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporterMolecular definition of deletions of different segments of distal 5p that result in distinct phenotypic features.Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.Genetic contributions to attentional response time slopes across repeated trials.Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridiniumGenetic biomarkers of depressionFine-mapping reveals novel alternative splicing of the dopamine transporter.Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter.
P2860
Q21262013-F5DA55D0-4F8B-4A50-83E9-CE571F1620ACQ24304882-3E98CC71-0C62-463A-B0F4-D36CAD8C3D0DQ24612997-C960C546-1714-4072-BF31-F99A1CCE68EAQ24626475-51AC8FFE-E016-4B81-AE9E-E243E0BC9892Q25255374-2B0F1DFA-28F9-4A22-BA00-A344798E42DFQ26781397-C58E5A5D-DCB3-4737-9078-5260A076F0A7Q26801298-A0A06A28-3EC2-4EBD-8199-8250C79219C8Q28071580-38D4910D-4036-44B6-B285-E3AE97A4D530Q28363107-5C71DB71-9763-4D6B-9844-85716A949595Q28365852-2AF364A0-69F6-4C54-930E-EE6A8879EF78Q28748883-068FAE2D-2710-4267-A2E9-E3BB373481FBQ30397145-CFD1966B-D365-4296-8AC7-9EE0C5F79D5AQ30404784-A2580FED-F255-4E1D-A80A-B06C6BD6BA72Q30439090-4AA21C35-21A7-4C9D-A187-64DF1D45A0BEQ30523972-DE899B31-B99D-4B79-A676-54F4176261EFQ33567582-ED788037-5CA7-4DCA-8B53-92DB8BBFB97CQ33623987-A1A72920-DFB3-41CF-93CA-BB4B8CE58254Q34001485-B921ED8A-F2FD-43F5-9449-BF83A316F2DAQ34008236-3357374A-F60A-4673-A4B9-8367E71B7658Q34010632-5E419C5F-26A0-492D-900A-0C34A5A3CF78Q34092655-DA7DB9A7-B186-4CD0-9906-44C30561F1ECQ34155796-23250076-8BFB-46B3-8635-954FCB9B403BQ34163247-748FFB32-BFC5-4AC2-8CAC-C459633C0008Q34170768-3B95C1A6-0816-4BFD-A6E3-0163928D0640Q34216604-EC461113-92FE-459C-A406-9AD9CF0868FAQ34540543-42F9A8D4-E893-4890-9E86-E6E603045544Q34568367-0C06BC8C-D039-4AC7-AB18-AB2FFEADBBCBQ34673305-879946CE-4051-4BF2-A56B-A3343DECF620Q35066854-52D901ED-BA4E-4EC6-824C-C23A31A66F6DQ35389745-93768C44-3201-42AA-A458-1A110A35D21EQ35450098-480E37A8-1090-4488-BFDA-3749AAB0AC24Q35545334-FF099C1A-C17C-4F7C-94AA-CD7A914FEA8CQ35644261-767EF869-B27E-4231-8226-9FE7DF1D3F24Q35733219-FAF723F5-5528-422B-B5DB-9CEAF6A46860Q35809354-F577B41E-E68F-4339-86A1-2DA703032BEBQ35993022-4A1BB251-A2A2-4F4D-A980-60404D9C9AB5Q36064163-AE1231F6-EE2C-48A4-9F50-3B462274AEFBQ36074954-51CE9EA3-2FA1-4AAB-A5E9-71E8563145C6Q36092017-9BFCA61C-78D2-4A6F-A2E3-7114923ED3D0Q36254171-FFF58C11-6B0F-4688-BCCA-50CA38CF2755
P2860
Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Cloning, pharmacological chara ...... he human dopamine transporter.
@ast
Cloning, pharmacological chara ...... he human dopamine transporter.
@en
type
label
Cloning, pharmacological chara ...... he human dopamine transporter.
@ast
Cloning, pharmacological chara ...... he human dopamine transporter.
@en
prefLabel
Cloning, pharmacological chara ...... he human dopamine transporter.
@ast
Cloning, pharmacological chara ...... he human dopamine transporter.
@en
P2093
P1476
Cloning, pharmacological chara ...... the human dopamine transporter
@en
P2093
Yang-Feng T
el Mestikawy S
P304
P577
1992-09-01T00:00:00Z